# A Randomized, Placebo-controlled Clinical Trial of Teneligliptin as Quadruple Oral Combination Therapy for Type 2 DM After Failure of an Oral Triple Anti-diabetic Regimen

> **NCT04446026** · PHASE4 · COMPLETED · sponsor: **Yonsei University** · enrollment: 100 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** teneligliptin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04446026
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-08
- **Primary completion:** 2020-12-07
- **Final completion:** 2021-05-17
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2021-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04446026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04446026, "A Randomized, Placebo-controlled Clinical Trial of Teneligliptin as Quadruple Oral Combination Therapy for Type 2 DM After Failure of an Oral Triple Anti-diabetic Regimen". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04446026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*